MIGUEL QUIRÓS OLOZÁBAL-rekin lankidetzan egindako argitalpenak (11)

2022

  1. Zinc 1,2,4-triazolo[1,5-a]pyrimidine Complexes: Synthesis, Characterization and their Effect Against Chagas Disease

    Medicinal Chemistry, Vol. 18, Núm. 4, pp. 444-451

2020

  1. Anti-diabetic and anti-parasitic properties of a family of luminescent zinc coordination compounds based on the 7-amino-5-methyl-1,2,4-triazolo[1,5-a]pyrimidine ligand

    Journal of Inorganic Biochemistry, Vol. 212

  2. First example of antiparasitic activity influenced by thermochromism: Leishmanicidal evaluation of 5,7-dimethyl-1,2,4-triazolo[1,5-a]pyrimidine metal complexes

    Medicinal Chemistry, Vol. 16, Núm. 3, pp. 422-430

  3. Lanthanide(III) Based Complexes Containing 5,7-Dimethyl-1,2,4-triazolo[1,5-a]pyrimidine as Long-Lived Photoluminescent Antiparasitic Agents

    European Journal of Inorganic Chemistry, Vol. 2020, Núm. 3, pp. 308-317

2019

  1. High antiparasitic activity of silver complexes of 5,7-dimethyl-1,2,4-triazolo[1,5 a]pyrimidine

    Journal of Inorganic Biochemistry, Vol. 201

2014

  1. Triazolopyrimidine compounds containing first-row transition metals and their activity against the neglected infectious Chagas disease and leishmaniasis

    European Journal of Medicinal Chemistry, Vol. 85, pp. 526-534

2012

  1. In vitro anti-leishmania evaluation of nickel complexes with a triazolopyrimidine derivative against Leishmania infantum and Leishmania braziliensis

    Journal of Inorganic Biochemistry, Vol. 112, pp. 1-9

  2. Structural consequences of the introduction of 2,2′-bipyrimidine as auxiliary ligand in triazolopyrimidine-based transition metal complexes. in vitro antiparasitic activity

    Polyhedron, Vol. 33, Núm. 1, pp. 137-144

2010

  1. In vitro and in vivo trypanocidal evaluation of nickel complexes with an azapurine derivative against trypanosoma cruzi

    Journal of Medicinal Chemistry, Vol. 53, Núm. 19, pp. 6964-6972

2009

  1. Copper (II) complexes of [1,2,4]triazolo [1,5-a]pyrimidine derivatives as potential anti-parasitic agents

    Drug Metabolism Letters, Vol. 3, Núm. 1, pp. 35-44

2001

  1. Activity of Pt(II) and Ru(III) triazolopyrimidine complexes against parasites of the genus Leishmania, Trypanosomas and Phytomonas

    Metal-Based Drugs, Vol. 8, Núm. 3, pp. 119-124